Mizuho Slashes MSTR Price Target to $265 as Stock Tumbles Over 10%
By TrendSpider Editor
Mizuho analyst Dan Dolev confirmed a buy rating on Strategy Inc. (MSTR) while cutting the price target from $320 to $265, a move that lands as shares crater more than 10% in today's session to $134.04. Even with the reaffirmed buy thesis, the revised target represents a significant step-down in conv
Mizuho Slashes MSTR Price Target to $265 as Stock Tumbles Over 10%
Mizuho analyst Dan Dolev confirmed a buy rating on Strategy Inc. (MSTR) while cutting the price target from $320 to $265, a move that lands as shares crater more than 10% in today's session to $134.04. Even with the reaffirmed buy thesis, the revised target represents a significant step-down in conviction on the near-term upside case. MSTR is currently trading near the lower end of its 52-week range of $104.17 to $457.22, underscoring just how far the stock has fallen from its peak.
Key Drivers of the MSTR Stock Move
- Main Catalyst: Mizuho's Dan Dolev maintained a buy rating on MSTR but reduced the price target by $55, bringing it down from $320 to $265. The rating confirmation signals continued long-term optimism, but the target cut acknowledges mounting near-term pressure on the stock.
- Bull Case: Despite the haircut, the new $265 price target still implies roughly 98% upside from the current price of $134.04, suggesting Mizuho sees significant recovery potential even after adjusting its valuation assumptions.
- Bear Case: A 10.51% single-session decline places MSTR just 28% above its 52-week low of $104.17, and the analyst community is clearly walking back expectations. A price target reduction of this magnitude from a bull on the name signals that headwinds are difficult to ignore.
The forward setup for MSTR remains challenging. The stock is firmly in big-loser territory today, and Mizuho's target revision suggests that even supportive analysts are recalibrating around a more cautious near-term outlook. Strategy Inc. continues to operate as one of the most Bitcoin-correlated equities in the market, meaning any softness in crypto sentiment tends to amplify moves in MSTR on both the upside and downside. With shares now sitting well below the midpoint of the 52-week range and a confirmed buy from Mizuho still pointing to $265, the gap between current price and analyst consensus leaves room for interpretation, but also reflects the uncertainty baked into the current tape.
MSTR Analyst Ratings and Price Targets
Mizuho, through analyst Dan Dolev, confirmed its buy rating on Strategy Inc. while lowering its price target to $265 from a prior target of $320. This is the only analyst action on record in the current data set. The average price target across tracked actions stands at $265, consistent with Mizuho's revised figure. No upgrades or downgrades were issued alongside the target adjustment.
MSTR Seasonality
Early June has historically represented a transitional period for high-beta, crypto-adjacent equities, where momentum from spring rallies can fade as institutional portfolio rebalancing picks up heading into the summer months. For a stock as volatile as MSTR, seasonal patterns tend to be amplified relative to the broader market.
MSTR Relative Performance
MSTR's 10.51% decline today places it among the session's worst performers in the high-beta growth and crypto-proxy category. Trading at $134.04 against a 52-week high of $457.22, the stock has given back a substantial portion of its prior run, underperforming broader market benchmarks by a wide margin on the day and reflecting the elevated downside volatility that has historically characterized MSTR relative to traditional equities and even Bitcoin itself.
More on MSTR
- Strategy Inc Surges Nearly 6% as MSTR Bounces Off Multi-Month Lows
- Strategy Inc Jumps Nearly 6% Friday as MSTR Bounces From Depressed Levels
- Strategy Inc Bears Bet $7.8 Million on Further Downside With a Deep ITM Put Into January 2027
- Strategy Inc Surges 8.19% as MSTR Reclaims Triple Digits Ahead of Holiday Weekend
- Strategy Inc Surges 8.19% But Remains Deep in Its 52-Week Trough
Latest Market News
- Netflix Beats Q2 2026 Earnings Per Share but Revenue Miss Sends Stock Below 52-Week Low
- Abbott Laboratories Tops Q2 2026 Earnings and Revenue Estimates, Shares Rise Nearly 2%
- ARM Holdings Sees $4.46M Bearish Put Sweep as Stock Trades Near Midpoint of 52-Week Range
- Amazon Unusual Options Activity: A $1.16M Put Contract Signals Potential Downside Ahead
- Visa Stock Slips 1.7% After Touching 52-Week High of $365.14
- UnitedHealth Group Crushes Q2 2026 EPS by 31.5%, Shares Climb Toward 52-Week High